Physician
Oncology
Dr. Paul J. Lemarbre, MD
|
|
Give Review
Paul J. Lemarbre is an expert in the field of Oncology. He went to University of Minnesota Medical School. University of Minnesota Medical School is ranked 40 in research and 10 in primary care medicine He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Paul J. Lemarbre, MD is a published doctor. He published 9 publications, including: 'Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic breast carcinoma.'
Publications
- Human pulmonary macrophage tumor Cell cytotoxicity.
- Lysozyme enhances monocyte-mediated tumoricidal activity: a potential amplifying mechanism of tumor killing.
- Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic Melanoma.
- Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic Breast carcinoma.
- Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic Melanoma: 5-year follow-up.
- Combined modality approach in the management of locally advanced head and neck Cancer.
- Spurious E rosette formation in B cell chronic lymphocytic Leukemia due to monoclonal anti-sheep RBC antibody.
- Metastatic islet cell amphicrine Carcinoma of the pancreas. Association with an eosinophilic infiltration of the skin.
Schools
University of Mn Med Sch
Dartmouth Hitchcock Medical Center
Dartmouth
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Dartmouth-Hitchcock Medical Center -
University of Minnesota at Fairview -
University of Minnesota Medical School
Hospital
-
Froedtert Memorial Lutheran Hospital